ERBB2 and breast carcinoma: Recently, Peddi et al. reported genotyping results from probably the largest dataset thus far, with 666 of the 3222 patients with early HER2-positive breast cancer included in the Breast Cancer International Research Group (BCIRG)-006 trial [39].